Item Type | Name |
Academic Article
|
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
|
Academic Article
|
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
|
Academic Article
|
Regulation of tumor angiogenesis by EZH2.
|
Academic Article
|
Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
|
Academic Article
|
The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
|
Concept
|
Cell Communication
|
Concept
|
Cell Cycle
|
Concept
|
Carcinoma, Squamous Cell
|
Concept
|
Cell Movement
|
Concept
|
Cell Line, Transformed
|
Concept
|
Cell Count
|
Concept
|
Cell Division
|
Concept
|
Clone Cells
|
Concept
|
Cell Transformation, Viral
|
Concept
|
Carcinoma, Transitional Cell
|
Concept
|
Cell Adhesion
|
Concept
|
Cell Transformation, Neoplastic
|
Concept
|
Cells, Cultured
|
Concept
|
Cell Differentiation
|
Concept
|
Carcinoma, Renal Cell
|
Concept
|
Epithelial Cells
|
Concept
|
Cell Nucleus
|
Concept
|
HeLa Cells
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
KB Cells
|
Concept
|
Adenocarcinoma, Clear Cell
|
Concept
|
Cell Hypoxia
|
Concept
|
Cell Line
|
Concept
|
Cell Nucleolus
|
Concept
|
Cell Survival
|
Concept
|
Cell Size
|
Concept
|
Cell Shape
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
3T3 Cells
|
Concept
|
Jurkat Cells
|
Concept
|
HCT116 Cells
|
Concept
|
Erythroid Precursor Cells
|
Concept
|
Cell Proliferation
|
Concept
|
Stromal Cells
|
Concept
|
Cell Lineage
|
Concept
|
Germ Cells
|
Concept
|
Neoplasms, Germ Cell and Embryonal
|
Concept
|
Cell Death
|
Concept
|
MCF-7 Cells
|
Concept
|
Single-Cell Analysis
|
Concept
|
Endothelial Cells
|
Concept
|
Cell Line, Tumor
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Carcinoma, Small Cell
|
Concept
|
Neoplastic Cells, Circulating
|
Concept
|
Hybrid Cells
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
K562 Cells
|
Concept
|
Neoplastic Stem Cells
|
Concept
|
Cell Cycle Proteins
|
Concept
|
CHO Cells
|
Concept
|
Cell Culture Techniques
|
Concept
|
HL-60 Cells
|
Concept
|
Cell Dedifferentiation
|
Concept
|
COS Cells
|
Concept
|
Active Transport, Cell Nucleus
|
Concept
|
NIH 3T3 Cells
|
Concept
|
G2 Phase Cell Cycle Checkpoints
|
Concept
|
Cell Growth Processes
|
Concept
|
U937 Cells
|
Academic Article
|
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.
|
Academic Article
|
Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-independent growth in RAT1a cells.
|
Academic Article
|
Clear cell cancer of the ovary.
|
Academic Article
|
Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.
|
Academic Article
|
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.
|
Academic Article
|
Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
|
Academic Article
|
p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
|
Academic Article
|
Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
|
Academic Article
|
Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and Uterus.
|
Academic Article
|
Targeting the Nuclear Import Receptor Kpn?1 as an Anticancer Therapeutic.
|
Academic Article
|
Genomic analysis of epithelial ovarian cancer.
|
Academic Article
|
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
|
Academic Article
|
Ascites analysis by a microfluidic chip allows tumor-cell profiling.
|
Academic Article
|
Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
|
Academic Article
|
ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.
|
Academic Article
|
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
|
Academic Article
|
Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip.
|
Academic Article
|
Better therapeutic trials in ovarian cancer.
|
Academic Article
|
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
|
Academic Article
|
Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.
|
Academic Article
|
Dicer, Drosha, and outcomes in patients with ovarian cancer.
|
Academic Article
|
Calcineurin activates cytoglobin transcription in hypoxic myocytes.
|
Academic Article
|
Clear cell carcinoma of the ovary: a review of the literature.
|
Academic Article
|
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
|
Academic Article
|
A key role for early growth response-1 and nuclear factor-kappaB in mediating and maintaining GRO/CXCR2 proliferative signaling in esophageal cancer.
|
Academic Article
|
NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
|
Academic Article
|
Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.
|
Academic Article
|
Novel therapeutic targets.
|
Academic Article
|
Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth.
|
Academic Article
|
An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.
|
Academic Article
|
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
|
Academic Article
|
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.
|
Academic Article
|
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
|
Academic Article
|
EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.
|
Academic Article
|
Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents.
|
Academic Article
|
Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies.
|
Academic Article
|
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.
|
Academic Article
|
Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
|
Academic Article
|
Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
|
Academic Article
|
Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth.
|
Academic Article
|
Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.
|
Academic Article
|
Early tumor detection afforded by in?vivo imaging of near-infrared II fluorescence.
|
Academic Article
|
AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets.
|
Academic Article
|
A link between histone deacetylase inhibitors and NF- kappaB signaling.
|
Academic Article
|
Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
|
Academic Article
|
TGF-? modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
|
Academic Article
|
Restoration of an impaired TGF-beta1 autocrine growth-inhibitory circuit results in growth inhibition of ovarian epithelial cancer cells and complete inhibition of their tumorigenicity.
|
Academic Article
|
The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.
|
Academic Article
|
Early events in the pathogenesis of epithelial ovarian cancer.
|
Academic Article
|
FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.
|
Academic Article
|
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
|
Academic Article
|
Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
|
Academic Article
|
Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure.
|
Academic Article
|
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
|
Academic Article
|
DNA copy number abnormality of oral squamous cell carcinoma detected with cDNA array-based comparative genomic hybridization.
|
Academic Article
|
Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer.
|
Academic Article
|
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles.
|
Academic Article
|
Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
|
Academic Article
|
Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.
|
Academic Article
|
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.
|
Academic Article
|
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
|
Academic Article
|
Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.
|
Academic Article
|
Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.
|
Academic Article
|
Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target.
|
Academic Article
|
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
|
Academic Article
|
Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.
|
Academic Article
|
Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary.
|
Academic Article
|
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
|
Academic Article
|
The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.
|
Academic Article
|
Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.
|
Academic Article
|
RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential.
|
Academic Article
|
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.
|
Academic Article
|
Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells.
|
Academic Article
|
Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.
|
Academic Article
|
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
|
Academic Article
|
Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes.
|
Academic Article
|
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer.
|
Academic Article
|
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.
|
Academic Article
|
Retinoblastoma protein-mediated apoptosis after gamma-irradiation.
|
Academic Article
|
Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts.
|
Academic Article
|
CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
|
Academic Article
|
Age-dependent changes in breast cancer hormone receptors and oxidant stress markers.
|
Academic Article
|
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
|
Academic Article
|
Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
|
Academic Article
|
The regulation of tumor suppressor genes by oncogenes.
|
Academic Article
|
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression.
|
Academic Article
|
CD157 in ovarian carcinoma: how does it help us?
|
Academic Article
|
SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.
|
Academic Article
|
Biologic directed therapies in gynecologic oncology.
|
Academic Article
|
MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells.
|
Academic Article
|
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
|
Academic Article
|
Erratum for Elagib et al., Jun Blockade of Erythropoiesis: Role for Repression of GATA-1 by HERP2.
|
Academic Article
|
Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.
|
Academic Article
|
The origin of ovarian cancer?is it getting clearer?
|
Academic Article
|
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
|
Academic Article
|
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.
|
Academic Article
|
Time for action: a "sea change" in treatment strategies for rare types of epithelial ovarian cancer.
|
Academic Article
|
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.
|
Academic Article
|
HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells.
|
Academic Article
|
Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.
|
Academic Article
|
Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression.
|
Academic Article
|
Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor a-targeting antibody-drug conjugate, in patients with solid tumors.
|
Academic Article
|
The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
|
Academic Article
|
Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones.
|
Academic Article
|
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
|
Academic Article
|
Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
|
Academic Article
|
Activator protein-1 contributes to high NaCl-induced increase in tonicity-responsive enhancer/osmotic response element-binding protein transactivating activity.
|
Academic Article
|
Cell cycle and related protein.
|
Academic Article
|
Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models.
|
Academic Article
|
p21-activated kinase 3 (PAK3) is an AP-1 regulated gene contributing to actin organisation and migration of transformed fibroblasts.
|
Academic Article
|
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.
|
Grant
|
The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis
|
Grant
|
The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
|
Grant
|
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
|
Grant
|
Novel Biomarkers in Ovarian Cancer
|
Academic Article
|
Candidate biomarkers for application as intermediate end points of lung carcinogenesis.
|
Academic Article
|
Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
|
Academic Article
|
Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
|
Academic Article
|
A complex pattern of translational initiation and phosphorylation in L-myc proteins.
|
Academic Article
|
The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells.
|
Academic Article
|
L-myc cooperates with ras to transform primary rat embryo fibroblasts.
|
Academic Article
|
Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing.
|
Academic Article
|
Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer.
|
Academic Article
|
Characterization of measles polypeptides by monoclonal antibodies.
|
Academic Article
|
Rational targets for the early detection of lung cancer.
|
Academic Article
|
Early events in the neoplastic transformation of respiratory epithelium.
|
Academic Article
|
Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.
|
Academic Article
|
Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
|
Academic Article
|
The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation.
|
Academic Article
|
Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines.
|
Academic Article
|
p53: a frequent target for genetic abnormalities in lung cancer.
|
Academic Article
|
Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.
|
Academic Article
|
A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation.
|
Academic Article
|
The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs.
|
Academic Article
|
Antigenic variants of measles virus.
|
Academic Article
|
Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
|
Academic Article
|
Constitutive cJun expression induces partial macrophage differentiation in U-937 cells.
|
Academic Article
|
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|
Academic Article
|
Early detection of lung cancer.
|
Academic Article
|
Initiators and promoters of lung cancer.
|
Academic Article
|
Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
|
Academic Article
|
Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C.
|
Academic Article
|
The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
|
Academic Article
|
Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
|
Academic Article
|
Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
|
Academic Article
|
PACAP stimulates c-fos mRNAs in small cell lung cancer cells.
|
Academic Article
|
Regulation of nuclear oncogenes expressed in lung cancer cell lines.
|
Academic Article
|
Discoveries in the cell cycle and ovarian cancer.
|
Academic Article
|
AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells.
|
Academic Article
|
Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells.
|
Academic Article
|
RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
|
Academic Article
|
JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells.
|
Academic Article
|
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
|
Academic Article
|
Complementation analysis of measles virus mutants isolated from persistently infected lymphoblastoid cell lines.
|
Academic Article
|
Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun.
|
Academic Article
|
c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
|
Academic Article
|
Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells.
|
Academic Article
|
Mechanism of action of a dominant-negative mutant of c-Jun.
|
Academic Article
|
Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice.
|
Academic Article
|
Cooperation between retinoic acid and phorbol esters enhances human teratocarcinoma differentiation.
|
Academic Article
|
Altered cJUN expression: an early event in human lung carcinogenesis.
|
Academic Article
|
Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
|
Academic Article
|
Activation and inhibition of the AP-1 complex in human breast cancer cells.
|
Academic Article
|
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.
|
Academic Article
|
The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.
|
Academic Article
|
Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies.
|
Academic Article
|
Use of transcription factors as agents and targets for drug development.
|
Academic Article
|
The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin.
|
Academic Article
|
FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
|
Academic Article
|
Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells.
|
Academic Article
|
PACAP hybrid: a new PACAP receptor antagonist.
|
Academic Article
|
Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.
|
Academic Article
|
Alterations in differentiation and apoptosis induced by bufalin in cJun overexpressing U-937 cells.
|
Academic Article
|
The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes.
|
Academic Article
|
Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide.
|
Academic Article
|
PACAP(6-38) inhibits the growth of prostate cancer cells.
|
Academic Article
|
Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun.
|
Academic Article
|
Identification of domains of c-Jun mediating androgen receptor transactivation.
|
Academic Article
|
The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity.
|
Academic Article
|
Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.
|
Academic Article
|
Expression of human papilloma virus E7 protein causes apoptosis and inhibits DNA synthesis in primary hepatocytes via increased expression of p21(Cip-1/WAF1/MDA6).
|
Academic Article
|
Inhibition of the mitogen activated protein kinase pathway potentiates radiation-induced cell killing via cell cycle arrest at the G2/M transition and independently of increased signaling by the JNK/c-Jun pathway.
|
Academic Article
|
Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression.
|
Academic Article
|
p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma.
|
Academic Article
|
Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
|
Academic Article
|
Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint.
|
Academic Article
|
c-Jun triggers apoptosis in human vascular endothelial cells.
|
Academic Article
|
TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta.
|
Academic Article
|
Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis.
|
Academic Article
|
Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun.
|
Academic Article
|
c-Jun activation-dependent tumorigenic transformation induced paradoxically by overexpression or block of S-adenosylmethionine decarboxylase.
|
Academic Article
|
The role of p27 in endometrial carcinoma.
|
Academic Article
|
Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
|
Academic Article
|
In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancers.
|
Academic Article
|
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines.
|
Academic Article
|
RASSF6 is a novel member of the RASSF family of tumor suppressors.
|
Academic Article
|
Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.
|
Academic Article
|
Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.
|
Academic Article
|
An in situ cell to study phase transitions in individual aerosol particles on a substrate using scanning transmission x-ray microspectroscopy.
|
Academic Article
|
BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
|
Academic Article
|
FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.
|
Academic Article
|
Identification of LMX1B as a novel oncogene in human ovarian cancer.
|
Academic Article
|
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.
|
Academic Article
|
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062).
|
Academic Article
|
Neutralization of TGF? Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma.
|
Academic Article
|
Inhibition of Kpn?1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
|
Academic Article
|
Understanding the effect of mechanical forces on ovarian cancer progression.
|
Academic Article
|
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.
|
Academic Article
|
A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.
|
Academic Article
|
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
|
Academic Article
|
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
|
Academic Article
|
Single-cell analysis of ovarian myeloid cells identifies aging associated changes in macrophages and signaling dynamics.
|